Salbutamol Sulphate | Uncoated Oral Bronchodilator Tablets
IP 2 mg, IP 4 mg and BP 4 mg presentations, each expressed as salbutamol equivalent.
Usage: Prescribed management of reversible bronchospasm.
Category: Respiratory / Antiasthmatic drugs
Categories: Pharmaceutical Exporter India · Pharmaceutical Formulations India · WHO GMP Certified Formulations
Salbutamol Tablets IP/ BP is listed for pharmaceutical business-to-business enquiries. Exact active ingredients, formulation, strength, pack configuration and manufacturer details should be confirmed against the product label and approved technical documentation before ordering.
Salbutamol Tablets contain salbutamol sulphate equivalent to 2 mg or 4 mg salbutamol. Salbutamol (albuterol) is a short-acting beta-2 adrenergic agonist bronchodilator used for reversible airway narrowing. These are oral, uncoated tablets, not inhalers. Oral salbutamol generally has a slower onset and more systemic adverse effects than inhaled therapy, so inhaled treatments are usually preferred where suitable. Healthy Life Pharma Pvt. Ltd. and Healthy Inc are the manufacturer/export contacts stated in the supplied brief; verify current authorizations.
| Standard | Label strength | Per-tablet composition | Dosage form |
|---|---|---|---|
| IP | 2 mg | Salbutamol Sulphate IP equivalent to Salbutamol 2 mg; excipients q.s. | Uncoated tablet |
| IP | 4 mg | Salbutamol Sulphate IP equivalent to Salbutamol 4 mg; excipients q.s. | Uncoated tablet |
| BP | 4 mg | Salbutamol Sulphate BP equivalent to Salbutamol 4 mg | Uncoated tablet |
SKU: Salbutamol Tablets | Therapeutic category: Antiasthmatic / Bronchodilator / Short-acting beta-2 agonist. Packaging and shelf life must be confirmed from the approved label.
For low-dose oral tablets, relevant formulation controls include blend and content uniformity, segregation prevention, compression consistency, disintegration and stability. Suitable manufacturing methods depend on the approved master formula. Specific granulation methods, production equipment and batch capacity have not been independently verified.
Quality controls may include raw-material identity, assay, uniformity of dosage units, dissolution or disintegration, impurities, microbial quality where applicable, and stability under the relevant IP or BP specification. Acceptance criteria must be taken from the actual registered product specification, not assumed generic limits.
Salbutamol relaxes airway smooth muscle by stimulating beta-2 adrenergic receptors. It may be prescribed for reversible bronchospasm associated with asthma or certain obstructive airway diseases, depending on local approval. Oral salbutamol is not the preferred treatment for a sudden severe asthma attack and should not replace a prescribed rapid-acting inhaler or emergency treatment. It is not an antacid or anti-ulcer medicine.
For pharmaceutical supply and export enquiries, request current manufacturing licence, GMP evidence, certificates of analysis, stability data, country-specific product registrations and packaging specifications. CTD/ACTD dossiers, COPP, FSC, export destinations and trade terms are subject to documentary confirmation.
IP 2 mg, IP 4 mg and BP 4 mg uncoated tablets.
No. Oral tablets act systemically and generally have a slower onset and greater risk of systemic effects such as tremor and palpitations.
No. Seek urgent medical care for severe breathlessness; follow the prescribed emergency asthma plan.
No. Salbutamol is a bronchodilator used in respiratory care.
Use only on a qualified prescriber’s instructions. Dose and frequency vary with patient age, clinical response, coexisting conditions and local approved labelling. Do not exceed the prescribed dose or use tablets as a substitute for an emergency reliever inhaler. Paediatric dosing requires clinician supervision.
Possible effects include tremor, nervousness, headache, palpitations, fast heartbeat and muscle cramps. Higher doses may cause low potassium, changes in blood glucose or cardiac rhythm disturbances. Discuss use with a clinician if you have heart disease, arrhythmia, hyperthyroidism, diabetes or take other sympathomimetic medicines. Seek urgent care for worsening breathing, chest pain, fainting or severe allergic symptoms.
Store in the original packaging, away from excess heat and moisture and out of children’s reach. Follow the exact temperature and expiry instructions on the approved IP or BP pack; a 36-month shelf life or specific storage limit cannot be confirmed from the supplied composition.
For professional and B2B reference only. Prescription requirements, indications, certificates and manufacturing claims depend on current product approvals and documentation.